Medical Device Regulation (MDR) – Regulation 2017/745 (EU) on Medical Devices
The German counterpart to the term “Medical Device Regulation” is “Medizinprodukteverordnung”. The European Union (EU) Regulation 2017/745 will become binding throughout Europe on May 26, 2021. In this article you will find information on content and implementation regulations for the medical technology industry.
EU regulation tailored to medical technology
The “Regulation (EU) 2017/745 of the European Parliament and of the Council concerning medical devices” was enacted already on 5 April 2017. It replaces the formerly applied “Directive 93/42/EEC concerning medical devices”. This actually means for the medical technology sector that the EU regulation 2017/745 substitutes for the following previous guidelines:
- Directive 93/42/EEC concerning medical devices (MDD);
- Directive 90/385/EWG, Active Implantable Medical Devices (AIMDD)
The EU bodies opted for a separate regulation with regard to Directive 98/79/EC on in vitro diagnostic medical devices (IVD). This guideline did not find its way into the medical device regulation. It is replaced by the separately drafted EU Regulation “In-Vitro Diagnostic Medical Devices Regulation 2017/746 (IVDR).
Discover the suitable software for MDR compliance
Binding throughout Europe as of May 26, 2021
In contrast to the superseded directive, the EU Parliament’s new regulation has gained an international profile. Its binding validity extends to all EU member states from the key date of May 26, 2021. It should be noted here that as of October 2019, no national legal acts have yet been adopted by the individual member states. This also applies to German specifics, requirements and penal provisions to be enacted. A corresponding draft for a German implementing law does exist. Nevertheless, the Federal Ministry of Health anticipates transition periods.
According to the existing legal text, the a transition period of three years applies for the implementation (05/26/17 — 05/25/21*). After the deadline at the latest, you as a manufacturer are obliged to submit an MDR certificate. This is the only way you are allowed to introduce a product to the market for the first time.
*In the wake of the COVID-19 pandemic, the effective date of the regulation was postponed to May 26, 2021.
Aim and necessity of the new EU regulation
In essence, the new regulation aims at an optimized, uniform regulation for the market launch of medical technology products. The focus is on the factors of product safety and product quality.
For you as a market participant and user, the new EU regulation consists of a mix of familiar content from the previous Directive 93/42/EEC and far-reaching changes. Among the essential, substantive and procedural content for you and your industry are the following contents of the Brussels Regulation:
Rules for the classification of medical devices
New terms and rules lead to changes in the assignment of existing products to partially modified product classes. For example, these changes affect the product range of “Stand-alone software”.
Conformity evaluation procedure
Following the set of rules for classification, the conformity assessment procedure now also varies depending on the class.
Technical Documentation/Document Management System
The technical documentation according to Medical Device Regulation proves to be much more detailed. Benefits of control and documentation for the companies become clear when looking at the new underlying tabular scheme in detail. The subdivision into individual categories in a direct link with the associated detailed requirements forms the basis for a detailed technical documentation.
Clinical evaluations/clinical trials
Significantly increased requirements characterize this action item. This applies in particular to high-risk product groups.
Company responsibility/safety officer
A significant change for your company results from the requirement of the EU bodies for a responsible person in their organization to be accountable for regulatory compliance.
Quality management
The FDA Medical Device 21 CFR 820 (FDA = U.S. Food and Drug Administration) stipulates the requirements for management systems of medical device manufacturers. In this function, Device 21 CFR 820 is the counterpart to ISO 13485. The core requirement is that procedural instructions such as document control, procurement, development and production are documented and implemented analogously.
Market surveillance mechanisms
In particular, the mandatory use of the EUDAMED database provides greater transparency. It is available to both the public and direct competitors as an information medium. The characteristics of each medical device are mapped by means of appropriate links. Supply chain traceability is also possible.
Ways to comply with the Medical Device Regulation
To fascilitate timely compliance with the new regulation, you are called upon to act, if you hold a responsible position in your company. A coherent plan for the transition of your company to the Medical Device Regulation, both in terms of time and content, is a prerequisite for your success. High priority should be given to the life cycles of your medical device portfolio. Existing MDD certifications will lose their validity on May 26, 2024, according to EU regulations. Please note in your planning that your products already certified according to MDD must also complete the new conformity process to be established according to MDR. A protection of the “grandfather status” is not guaranteed.
In the transition phase, you are particularly challenged in your function as a manufacturer or provider. The highest priority is to designate and train the person responsible for regulatory compliance in your facility (MDR Article 15). Updates to internal quality assurance procedures, documentation, and modified product classification are mandatory.
Against this background, the following standardized procedure according to the following 4 points is recommended:
- Implementation of the conformity evaluation related to the product
- Completing a declaration of conformity
- “CE” marking of the products
- Registration of company and products in the EUDAMED database.
Conclusion and criticism of the new regulation
With the MDR, EU officials have set out to create a contemporary, uniform solution for quality management and market release of medical devices. Great attention is paid to the quality and safety of products. Perhaps you also belong to the group of small and medium-sized companies in the medical technology sector that fear over-regulation by the extensive set of regulations and additional auditing bodies?
Especially the assessment of the conformity by the “compliance manager” to be named could result in a staffing issue, at first. In a case of hardship, a shortage of certified auditors could delay the certification needed for market release. Medical technology industry associations express fears that a bottleneck in certifications could have a negative impact on the market launch of innovative and marketable products.